In conclusion, de novo synthesis of choline through PEMT plays an important role in regulating systemic energy metabolism, and the PEMT gene may be a pharmacological target for the treatment of obesity and insulin resistance. This evidence concerns the gene PEMT and obesity due to melanocortin 4 receptor deficiency.